Noopur Raje, MD, on Unmet Needs With CAR T-Cell Therapy in Multiple Myeloma

The director of the Center for Multiple Myeloma and Mass Gen discussed unmet needs with CAR T-cell therapy in multiple myeloma.

CGTLive’s Weekly Rewind – May 27, 2022

Review top news and interview highlights from the week ending May 27, 2022.

Developing Safer Viral Vectors for Gene Therapy

The chief executive officer of Ring Therapeutics, Tuyen Ong, MD, discussed the potential of anellovirus vectors for use in gene therapy.

Amy Pooler, PhD, on Improving Gene Delivery to the CNS

The vice president of neuroscience at Sangamo Therapeutics discussed identifying novel capsids with improved neuronal transduction to the CNS.

Around the Helix: Cell and Gene Therapy Company Updates – May 25, 2022

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Jason Fontenot, PhD, on Reducing the Need for Immunosuppression in Renal Transplantation

The chief scientific officer of Sangamo Therapeutics discussed the first-in-human STEADFAST trial.